🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06350045
Active, not recruiting Phase 4

High Supracostal Versus Subcostal Puncture in Adult PCNL

NCT06350045 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 4
Started
2024-03-01
Last updated
2024-04-05

Condition(s) studied

Urolithiasis

Investigational drug(s) / intervention(s)

PCNL

PCNL: percutaneous nephrolithotomy

Study summary

as the supra eleventh puncture PCNL is not well investigated in the literature we will conduct that randomised trial in comparison to the subcostal one

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age ≥ 18 years old. * Patients amenable for PCNL with stone burden between 2 cm - 4 cm (guy score 1-2-3) Exclusion Criteria: * Ectopic kidney. * Single middle calyceal stone. * Skeletal anomalies. * Bleeding diathesis. * Active urinary tract infection. * Patient refusing participation. * Patients with active pulmonary and pleural disease.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Assiut University Hospital Asyut Egypt

More Assiut University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06350045 on ClinicalTrials.gov ↗ ← All trials in Egypt